We have observed clinically meaningful reductions in A1C levels by up to 2.0% in patients with type 2 diabetes, alongside enhancements in cardiometabolic risk factors such as non-HDL cholesterol, triglycerides, and systolic blood pressure
However, researchers have conducted many studies with small sample sizes, short intervention periods, and frequent use of co-supplementation, which limits the ability to isolate the effects of individual compounds
Ge L, Wang K, Lin H, Tao E, Xia W, Wang F, et al
Has shown to help calm down inflammation in skin
N Engl J Med 2023;388:117-27.ArticlePubMed 50
Preclinical Research Status# Klotho peptides (KP1, KP6) are preclinical research compounds that have not been tested in humans